COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement on Resolutions of the Second Meeting of the Fifth Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd.

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Industry Announcement No.: 2013-029

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on Resolutions of the Second Meeting of the Fifth Board of Directors

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the company") The second meeting of the fifth board of directors was held on August 1, 2013 by means of communication voting. The meeting was notified by phone, email on July 20, 2013. In the same way, the meeting should be attended by 7 directors and 7 actual attendees. The convening of this meeting is in line with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid. After careful consideration by the attending directors, the following proposals were passed:

 

The “Proposal on Applying for Working Capital Loans to Changchun Ruixiang Sub-branch of Jilin Bank Co., Ltd.” was considered and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

 

1. Apply to Changchun Ruixiang Sub-branch of Jilin Bank Co., Ltd. for a working capital loan of no more than RMB 200,000 for ginseng procurement with a loan term of one year.

 

2. The guarantee method of the above loan is pledge, specifically the ginseng product with the book value of the company and its subsidiary of 32.96 million yuan as the pledge.

 

3. Authorized financial manager Shao Tianyu has full authority to handle the loan procedures.

 

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

August 2, 2013